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GLOBAL EPIDEMIOLOGY TODAY
In presenting some thoughts on perspectives in global epidemiology, I want
to emphasize that we are dealing with a moving picture that changes not
only from place to place, but also in time over the centuries, year by year,
and even day by day. Imagine the evolution of the world, speeded up so that
years pass in seconds, and centuries in minutes. Far back in history there
were small foci of human activity about which we know little. Gradually
these foci extended and in certain areas there were sudden increases which
were the early great civilizations. Imagine the thriving, bustling life in these
early cities, confident in the future, when suddenly something happened and
it disappeared. In the time scale we are imagining, in a few seconds or a
minute or so there is nothing left except stones and bones for archeologists.
What happened? In most instances we do not know precisely. Sometimes it
was doubtless the depredations of neighboring groups, more virile and
aggressive, but without the knowledge or intellectual capacity to maintain
and continue the development of the civilization they had conquered.
Sometimes the civilization destroyed or damaged itself unwittingly by its
interference with the ecological situation in which it existed. Irrigate and
build reservoirs, and you build breeding places for mosquitoes. Malaria may
destroy a civilization, as is believed to have happened in Ceylon. Build
houses with cellars and unprotected grain stores-domestic rodents will
increase, and plague and typhus will follow. Ship negro slaves across the
Atlantic forprofit-their viruses travel with them, and the planters purchase
Yellow Jack as well as labor. Medical historians can certainly provide many
other examples of the results of man's ignorance. And ignorance is, in the
long run, more dangerous than aggression.
The examples I have given are well known, and we do our best to avoid
such risks. But what of the unknown or unrecognized dangers we are
facing now? The changes in man's ecology which have taken place in the
last century have been greater than the previous changes in the whole of
man's known history. I use the word changes rather than the word progress
deliberately. Only the future will show whether we have made progress or
whether we are building something that may eventually destroy us. I believe
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that this is no exaggeration, and I am not speaking only of the dangers of
nuclear explosions and radiation hazards. Dr. John R. Paul,' at the Third
International Poliomyelitis Conference, pointed out that our technical skill
may have outstripped our ability to apply it intelligently. For example,
improved hygiene and sanitation which has rid the major part of the more
highly developed parts of the world of typhoid and cholera has been at least
partly responsible for the great increase in poliomyelitis.
Man and man-made changes in the environment are only part of the total
ecological picture. Vectors and infectious agents are also evolving and
undergoing both spontaneous changes due to mutation and natural selection
and changes in behavior or structure due to the pressure of the environment.
Most of these changes cannot be foreseen, nor can they be prevented. But
they must be watched for constantly and investigated promptly in a search
for a remedy.
A recent and grave example of this came to light during the World
Health Organization's (WHO's) Malaria Control Program, when certain
mosquitoes developed resistance to insecticides, due apparently to some
genetic change not yet understood. This makes eradication of the disease
urgent while we still have insecticides to which the vectors are susceptible.
Of course, the search for new and more effective insecticides continues, but
we do not known how long the chemists will succeed in keeping ahead of
the natural defenses of the vectors.
The evolution of infectious agents may be illustrated by considering the
influenza A virus, which seems to be one of the most unstable viruses in
certain respects, with the result that we have been able to observe several
changes in the short period since we learned how to study it.
Modern influenza may be said to have begun in 1889. Epidemics believed
to have been due to influenza have been described at intervals for centuries,
but in the latter part of the nineteenth century the incidence, in Europe at
least, fell to very low figures: the disease almost disappeared in the 1880's
until suddenly in 1889, apparently in Asia, an epidemic began which spread
throughout the world in successive waves during the following years. The
position before 1889 has never been regained. Although the first influenza
virus, the swine virus, was discovered by Shope' only in 1929, and the first
human strain by Wilson Smith, Andrewes, and Laidlaw' in 1933, we have,
through serological studies, some evidence of what happened before. The
studies of Davenport et al.'-8 provided evidence that a virus related to the
swine virus had been present in man about the time of the 1918 pandemic
and that the known groups of influenza A virus infected man over more or
less well-defined periods, after which they disappeared, apparently com-
pletely, in a short time. Early in the 1957 pandemic Mulder,' confirmed by
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others, showed that certain persons who had lived through the period of the
1889 pandemic had antibodies to the new Asian virus, suggesting that a
member of the same group of viruses might have been responsible. Further-
more, these persons usually had a higher level of antibody to the Asian
virus than to more recent strains and reacted to the stimulus of vaccine in
a way which suggests that their primary stimulus, or "original antigenic
sin" as Davenporteput it, was indeed with thatvirus, or a closely related one.
I shall return later to the puzzling question as to where this virus might
have persisted.
It seems that in the last 70 years there have been at least five major
antigenic shifts in the influenza A virus. In 1889 a virus apparently related
to the Asian virus appeared, in 1918 the swine virus, in 1934 or thereabouts
the prototype human A strain PR8 (I omit WS since this is now considered
to belong to the PR8 group although it is somewhat apart), in 1946-47 the
FM1 or Al group appeared and the A group vanished, and most recently
but certainly not finally, in 1957 the Asian or A2 group appeared, and it
looks very much as if the Al group has disappeared.
In addition to these major shifts in which it is difficult to show any
relationship between the different groups by the hemagglutination-inhibition
(HI) test, there have also been many lesser antigenic changes suggesting
a continuous evolution of the virus under pressure of the antibody spectrum
of the human population, changes doubtless facilitating the survival of the
virus and its ability to cause epidemics in man. These changes have been
studied during the last 10 years under the WHO Influenza Program,"which
is a good example of the way the quarrelsome human race can at times
forget its differences and co-operate in a concerted investigation of a world-
wide problem, which by reason of its nature can only be investigated in
this way.
Apart from their scientific interest these changes are of practical
importance in the selection of strains for incorporation in vaccines. True,
the change from one epidemic to the next may not be sufficient to make
vaccines prepared with the previous strain ineffective, but in the course of a
few years the progressive change becomes so great that a recent strain must
be incorporated in the vaccine. The periodic major antigenic shifts of course
demand the inclusion of the new variant. Thus it is necessary to keep a
continuous watch on the antigenic make-up of the influenza virus and that is
the major function of the WHO Influenza Program. We must also watch
for changes in virulence. That is much more difficult to measure, but
happily so far whatever it was that happened in 1918 has not recurred.
Another part of the program is the study of the spread of influenza. It
seems that there are two principal methods, one being the appearance of a
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new variant in one place, followed by continuous spread from there. This
was observed in 1949 when a virus recognizably different from previous
strains originated in Sardinia and spread northward through Europe.' The
same was observed even more impressively in 1957,1' when the Asian virus
appeared in South China and spread throughout the world (Fig. 1). The
other method of spread seems to depend on the fact that in the intervals
between the great pandemics influenza may behave as an endemic disease
which periodically takes on anepidemic form. Sometimes new variants of the
same group appear almost simultaneously in widely separated parts of the
world, causing more or less extensive outbreaks. It would seem that when
the immunity status of different populations is similar, the resulting selective
pressure on virus mutation and the direction of successful mutation, are also
similar so that the same new variant may appear independently in widely
separated areas.
However, the appearance of the Asian virus cannot be explained in this
way. I have already mentioned its possible relationship to the 1889 virus and
that raises the question as to whether this virus has, in fact, persisted since
1889, and if so, where. It is noteworthy that the pandemics of 1889 and
possibly also those of 1830and 1782 appear to have begun in China. There is
a possibility that influenza virus may have persisted in an animal host. We
know that viruses belonging to the A group naturally infect swine, horses,
ducks, and fowls, in addition to man. The swine virus was apparently once
a human virus which has persisted with very little change in antigenic
structure for 40 years in swine. The absence of antigenic change in this
usually unstable virus may be due to the absence of the selective pressure of
pre-existing antibody in the pig population, which is regularly replaced by
slaughtering and rearing fresh nonimmunes. Perhaps the Asian virus per-
sisted, similarly unchanged, in swine or some other animal host. Some of the
properties of thevirus, including its susceptibility to nonspecific inhibitors in
various animal sera and the capacity to produce hemagglutination with cells
of species not normallyagglutinated by viruses of human origin lend support
to this hypothesis.
During the recent pandemic Dr. Kaplan and I' at WHO initiated a study
of this problem by arranging the collection of sera from animals (swine and
horses) in 25 countries before the pandemic arrived, followed by collection
of sera from, as far as possible, the same animals after the human wave had
passed. The results suggest that the Asian virus was not present in these
animals before, but caused infection in some of them during the pandemic.
Time does not permit detailed discussion, but the importance of further
investigations is evident. It would appear that these should be carried out
also at the point of origin of the pandemic and include studies of both the
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domestic and wild animal populations there. Unfortunately, China is the
one part of the world which the WHO network cannot at present reach.
Efforts have been made to stimulate this investigation and are continuing,
but so far without success. I mention this to emphasize once more the
importance of truly worldwide study of disease problems common to the
whole world.
It will be clear that the central theme of these remarks is the importance
of studying changes in man, in his environment, and in infective agents and
their possible influence on disease patterns. Different parts of the world are
changing at different rates-in some areas conditions seem to be much as
they were several thousand years ago, in others, conditions exist which have
never before been seen on earth. If, therefore, we undertake comparative
studies of the existing disease patterns in populations in different areas and
in different stages of development, we may obtain evidence as to the influ-
ence of past environmental changes on diseases and indications as to the
trends which may be anticipated in the future. This is what we need to
know to avoid those unknown pitfalls which may lie before us, and also to
help newly developing countries from making the same mistakes which we
have made.
The best example of this is poliomyelitis since, thanks largely to the
pioneer work of Dr. Paul and his colleagues7 at Yale, we can see actually
happening in different parts of the world today the same pattern of evolu-
tion of the disease as was experienced in this country over the past century.
Furthermore, it is a pattern that may well be followed by other virus infec-
tions of similar epidemiology. Indeed, there are indications that this has
already begun, in the recognition of epidemic aseptic meningitis and other
diseases due to Coxsackie and ECHO viruses, and, perhaps more serious,
the grave form of encephalomyocarditis neonatorum described by Gear.' It
seems probable that the latter only occurs in infants without the protection of
maternal antibody. As more women reach maturity without experiencing
Coxsackie B infection, we may expect this serious condition to become more
common and, if nothing is done, to occur in epidemic form.
Let us therefore look at the pattern of poliomyelitis in different parts of
the world, regarding it not simply as a study of poliomyelitis but as a model
of how we may expect other enterovirus infections to behave in the coming
years. Of course we cannot expect this extrapolation to be correct in all
details; for example, the probability that an infection will produce clinical
disease in susceptibles of different age groups is not necessarily the same for
different viruses. It may be that Coxsackie B tends to produce serious
disease most frequently in infants, whereas poliomyelitis seems to produce
paralysis least frequently in that age group. Figure 2' summarizes the
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immunity status to poliomyelitis of populations in different parts of the
world. I have departed from the conventional method of presenting these
data because I think that this presentation shows more clearly the change in
the rate of acquisition of immunity, or rather loss of susceptibility, in areas
in different stages of development. Here you see the familiar pattern of rapid
loss of susceptibility in areas of low standards of hygiene and sanitation,
followed progressively by a slowing down of the process as these standards
are raised, until in the most highly developed communities natural immuni-
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zation is a very slow process which may never be completed. I would like to
emphasize that although on this figure reference is made to countries, in fact
one may find thewhole range shown within the same country in the different
socio-economic groups, when there is a wide variation in economic status.
This must be borne in mind when quoting a figure purporting to represent
the country as a whole. At best it is only an estimate of the average situation,
and if the population sampled is not well chosen, the result may be mis-
leading. However, in many instances such investigations have proved useful
and to correlate satisfactorily with the age incidence of paralytic disease
when reasonably reliable figures are available for the latter. It is therefore
justifiable to assume that information such as this enables one to predict the
age distribution of an epidemic of paralytic poliomyelitis, should that occur.
In practice that expectation has been borne out.
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This information does not enable one to predict when an outbreak will
occur, nor its probable severity. All one can say is that outbreaks are more
likely the slower the rate of loss of susceptibility, and that they generally
tend to be more severe. There is another indicator which is simpler, but
probably less reliable. As shown in Figure 3, a fall in the infant mortality
rate is associated with a marked rise in the mean incidence of poliomyelitis.
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FIG. 3. Infant mortality rates, indicated by cross-hatched vertical columns; polio-
myelitis cases, per million population, indicated by black vertical columns (adapted
from Payne, ref. 11, p. 396).
Dr. Paul, in studies in South America,9 has produced further evidence in
support of this. Briefly, when the infant mortality rate falls below about
75/1,000 livebirths, one may expect the poliomyelitis incidence to increase to
3-4/100,000 total population. With lower infant mortality, the median
incidence may become very much higher.
This is, however, by no means the invariable rule and recently very
severe outbreaks have been observed in countries with high infant mortality
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rates. It is necessary to look for another explanation of this phenomenon.
In my opinion the pattern of epidemics in different parts of the world since
the mid-1940's suggest that there has been a spread throughout much of the
world of strains of type 1 virus of heightened virulence for the human
nervous system. That this change, if it has occurred, has not been associated
with any significant antigenic variation, is shown by the fact that the disease
is practically confined to infants in those areas where that would be
expected; older children and adults have been naturally immunized by the
previously prevalent strains. It is indeed fortunate that poliovirus does not
behave like the influenza virus. We are not entitled to say that that will
never occur, but consideration of the history of poliomyelitis in the past
and studies of the world situation today make it seem unlikely. However, we
do not know how other enteroviruses will behave in this respect. If this
interpretation is correct, it becomes a matter of urgency to be able to
recognize strains of increased neurotropism, since they are those most likely
to break through vaccination, as occurred recently in Israel. Unfortunately
no simple tests are currently available. It is to be hoped that studies similar
to those now in progress on genetic markers associated with low virulence
might eventually lead to such a test. At any rate efforts should be made now
to collect and preserve as near as possible in their original state the strains
responsible for these outbreaks, so that they will be available for examination
later.
I have said that these lessons should also be applied to the other entero-
viruses. We need to know much more about the prevalence of these agents
in different populations, the rate at which immunity is being acquired, and
the antigenic structure of the prevalent viruses, especially those responsible
for clinical diseases but also those not at present known to cause disease,
since they may do so in the future. One hundred years ago one might well
have doubted the pathogenicity of poliovirus for man had one been able to
study it. We need this information so that we have a base line from which
we can measure future changes which may give warning of impending
trouble.
The epidemiological approach to many other different disease problems is
similar in principle. As well as undertaking detailed epidemiological studies
of individual diseases, we need to map the world distributon of potential
pathogens, and to study their antigenic structure and other characteristics,
and we need to know which are infecting man, at what rate this is taking
place under different conditions, and what clinical disease is caused and
with what frequency in different age groups.
Some of this information can be obtained from properly designed sero-
logical surveys and this led me to propose a multi-purpose approach to such
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surveys, designed to provide the maximum amount of information from a
given investigation. In order to study and advise on this proposal, WHO
convened in December last year a study group, among the members of
which were a virologist, an epidemiologist, a bacteriologist, a veterinarian,
and a statistician, as well as a biochemist-nutritionist and an expert on
hemoglobins. The latter were included because it occurred to me that there
are a lot of other things in blood besides antibodies, the investigation of
which is of great importance in the study of health problems other than
communicable disease, and that many of the epidemiological and statistical
considerations in surveys for different purposes were likely to be similar in
principle. These include nutritional disorders, anemias, human genetics
(blood groups, abnormal hemoglobins), and others.
There are two main thoughts behind the proposed program. The first is
that if sera are collected according to statistically sound sampling methods,
so that they are truly representative of the population, then the past experi-
ence of the population with communicable diseases may be estimated by
studying the antibody content of the sera, using a wide variety of antigens.
The second is that there are many diseases prevalent today of which we do
not know the cause and it is certain that new agents will be isolated and new
clinical syndromes recognized in the future concerning which information
regarding their past history will throw valuable light on the evolutionary
trend. If, therefore, portions of these serum samples are stored under such
conditions as to preserve antibodies, they will be available in the future for
examination against antigens not yet discovered and, in comparison with
future surveys, provide evidence of the changing immunity status of popula-
tions. A great deal of valuable information has already been obtained by the
examination of the antibody patterns in different age groups. I have already
mentioned the influenza and poliomyelitis studies. But it is easy to see that
these collections would in the course of time yield much more definite
information which would be easier to interpret.
This approach of course has its limitations. Different samples may be
preferred for the study of different types of infection; some infections are
sharply limited in their geographical distribution and the infected area may
not have been included in the sample; in some instances owing to lack of
specificity of the test used it will only be possible to identify the presence of
members of a group of viruses and not the specific virus itself. However,
even in the latter instance the survey is of value in identifying areas where
further investigations are needed and the virus groups which should be given
special attention. It must be recognized that, valuable though they may be,
serological surveys give information on only one side of these problems.
Other investigations will always be needed to complete the ecological picture.
13YALE JOURNAL OF BIOLOGY AND MEDICINE Volume 32, September 1959
In studying human disease it is sometimes forgotten that many human
pathogens are also pathogens for various species of animals. In some infec-
tions animals are the primary hosts and infection of man an ecological acci-
dent of no significance for the survival of the agent. It is clear that studies
of the ecology of human disease will not be complete without studies of the
part played by animal infections. I have already mentioned the possibility
that animals may play a role in the ecology of influenza. It would come as a
surprise to many if eventually it were shown that influenza was primarily
a zoonosis! I am not suggesting that that is so, but investigation of the possi-
bility has hitherto been neglected. It is therefore proposed that the serologi-
cal approach mentioned, including the establishment of collections of sera,
would be applied to domestic and, as far as possible, to wild animals as well.
We have much to learn regarding the best way to carry out this rather
ambitious project. Pilot studies will be needed and-one has already been
initiated in Africa, using the multi-purpose approach, including hematologi-
cal and nutritional studies. It was interesting to find in one area that co-
operation was obtained because of the information which would be obtained
on nutritional problems and not on communicable diseases. If I had only
been able to offer the latter, I doubt whether the survey would have been
carried out.
Our plan is to encourage and support the establishment of reference banks
of sera in centers conveniently located in different parts of the world. A cen-
tral punch card index will be established so that information will be immedi-
ately obtainable as to what collections are available, the conditions under
which they were made with full epidemiological data, and the examinations
already performed, together with the results. Parts of these collections will
be made available for approved investigations anywhere in the world. If,
for example, in 1970 one of you should want to investigate the prevalence of
a particular agent (perhaps one not yet discovered) in Africa, say, in Kenya
in 1959 or in Nigeria where we did our first pilot study in 1956, we would
be able to locate and provide you with the necessary material.
I hope I have shown you that many, if not all, communicable diseases, and
many other diseases as well, are ultimately international problems and that
a full understanding of the changing patterns of disease can only be attained
by international co-operation and coordination of effort. This understanding
is needed for the protection of all peoples from the possible undesirable con-
sequences of man's massive interference with the ecological situation in
which he lives, as well as for the improvement of the lot of humanity now.
We do not want to risk our civilization ending in the same way as earlier
ones through our own fault.
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